Not long ago, some predicted that MannKind Corporation(NASDAQ:MNKD) faced the serious risk of striking out on winning approval for Afrezza. Instead, those predictions swung and missed. The U.S. Food and Drug Administration recently approved the inhaled ... ...

24 people liked this